Argus Research Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $780
Argus Research analyst David Toung maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $560 to $780.
Share
Why It Matters
An expert analyst still believes Thermo Fisher is a good company to own. They raised their price target, meaning they think it could be worth more money someday.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.